Clinical trial

Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery

NCT02334007

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-09-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2015-09-01Date precision: month

Registry last updated2018-09-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Venous Thromboembolismunresolved

Lung Neoplasmsunresolved

Pulmonary Embolismunresolved

Interventions

LMWH: DalteparinDRUG

PlaceboOTHER

Sponsors & collaborators

McMaster Universitylead sponsor

Mapped research locations

TorontoOntario, Canada1 HamiltonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02334007 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.